Delivery Order SPE2DB20D1109-SPE2DB23FP51C
Award Date
7/12/23
Potential Completion Date
7/13/23
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3103|SPE2DB22FL5T1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,447.60 firm-fixed-price delivery order is for the drug methylergonovine 0.2 mg/ml to support military and veterans' healthcare programs. The award has an ultimate completion date of November 5, 2021 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $2,393.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567064635 - Methylergonovine 0.2 mg/ml vials, with a final completion date of January 29, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $1,007.70, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order contract with a Firm Fixed Price pricing type, and an ultimate completion date of February 19, 2025. The contract covers the procurement of 4567304287 units of Methylergonovine 0.2 mg/ml, a medication used to treat certain postpartum conditions. AmerisourceBergen holds a larger...
This federal contract award SPE2DB20D3103|SPE2DB25FN5Q0 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,196.66, is for the delivery of 4568013187 METHYLERGONOVINE 0.2 MG/ML VLML. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant...
This federal contract award, with an ID of SPE2DB22D3102|SPE2DB24FK9CS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of 4562970707 ! METHYLERGONOVINE 0.2 MG TABLET 28S, with an ultimate completion date of December 4, 2023 and a ceiling value of $1,988.64. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,410.20, is for the delivery of 4568112775 methylergonovine 0.2 mg tablets. The contract has a period of performance through May 5, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $3,146.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of 4563095243 - METHYLERGONOVINE 0.2 MG TABLET 12S, with a performance period through December 14, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with the ID SPE2DX15D6028|SPE2DX25FWJPV, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,673.90 fixed-price delivery order contract is for the provision of 4567516048 - METHYLPHE LA 30MG 100S, a pharmaceutical product. The contract has an ultimate completion date of April 4, 2025. Amerisourcebergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $5,202.06 firm fixed-price delivery order is for the supply of 4566035000 METHYLPHN ER 27MG 100S, a prescription medication product. The contract has an ultimate completion date of October 8, 2024 and was awarded on October 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
The Defense Logistics Agency awarded a $4,138.46 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.2 mg/ml vials of methylergonovine under contract number 4561936816. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical product from its facility in Conshohocken, Pennsylvania for use by the Department of Defense between August 24-25, 2023. No subcontractors or set aside designations were identified. The delivery order...